Your browser doesn't support javascript.
loading
Practice patterns for chronic hypoparathyroidism: data from patients and physicians in France.
Bertocchio, Jean-Philippe; Grosset, Natalie; Groussin, Lionel; Kamenický, Peter; Larceneux, Fabrice; Lienhardt-Roussie, Anne; Linglart, Agnès; Maruani, Gérard; Mirallie, Eric; Pattou, François; Seervai, Riyad N H; Sido, Coralie; Silve, Caroline; Vilfaillot, Aurélie; Tabarin, Antoine; Vantyghem, Marie-Christine; Houillier, Pascal.
Afiliación
  • Bertocchio JP; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.
  • Grosset N; Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France.
  • Groussin L; Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, INSERM, UMRS1138, Paris, France.
  • Kamenický P; Hypoparathyroïdisme France, Annecy, France.
  • Larceneux F; Department of Endocrinology, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université de Paris, Paris, France.
  • Lienhardt-Roussie A; Université Paris-Saclay, Inserm U1185, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate, Le Kremlin-Bic
  • Linglart A; Université Paris-Dauphine, PSL Research University, CNRS, UMR 7088, DRM [Ermes], Paris, France.
  • Maruani G; CHU Dupuytren, Hôpital Mère Enfant, Endocrinologie Pédiatrique, Limoges, France.
  • Mirallie E; Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France.
  • Pattou F; Université Paris-Saclay, Inserm U1185, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Service d'Endocrinologie et Diabète de l'Enfant, Centre de Référence des Maladies Rares du Calcium et du Phosphore et Filière de Santé Maladies Rares OSCAR, Hôpital Bicêtre P
  • Seervai RNH; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.
  • Sido C; Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR, Paris, France.
  • Silve C; Assistance Publique-Hôpitaux de Paris, Institut Necker-Enfants Malades, INSERM U1151 - CNRS UMR 8253, Paris, France.
  • Vilfaillot A; Chirurgie Cancérologique, Digestive et Endocrine, Institut des Maladies de l'Appareil Digestif, Hôtel Dieu, CHU Nantes, France.
  • Tabarin A; Association Francophone de Chirurgie Endocrinienne (AFCE), France.
  • Vantyghem MC; Université de Lille, CHU Lille, Institut Pasteur Lille, Inserm U1190, Lille, France.
  • Houillier P; Molecular & Cellular Biology Graduate Program, Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA.
Endocr Connect ; 11(1)2022 01 31.
Article en En | MEDLINE | ID: mdl-34939939
Context: Recent guidelines have provided recommendations for the care of patients with chronic hypoparathyroidism. Very little is known about actual physicians' practices or their adherence to such guidelines. Objective: To describe the physicians' practice patterns and their compliance with international guidelines. Design: The cohort studies included were Épi-Hypo (118 physicians and 107 patients, from September 2016 to December 2019) and ePatients (110 patients, November 2019). Methods: Internet-based cohorts involving all settings at a nationwide level (France). Participants were (i) physicians treating patients with chronic hypoparathyroidism and patients with chronic hypoparathyroidism either participating in the (ii) Épi-Hypo study (Épi-Hypo 2019 patients), or (iii) Hypoparathyroidism France, the national representative association (ePatients). Results: The physicians' specialties were mainly endocrinology (61%), nephrology (28%), family medicine (2.5%), pediatrics (2.5%), rheumatology (2%), or miscellaneous (4%) and 45% were practicing in public universities. The median number of pharmaceutical drug classes prescribed was three per patient. The combination of active vitamin D and calcium salt was given to 59 and 58% of ePatients and Épi-Hypo 2019 patients, respectively. Eighty-five percent of ePatients and 87% of physicians reported monitoring plasma calcium concentrations at a steady state at least twice a year. In 32 and 26% of cases, respectively, ePatients and physicians reported being fully in accordance with international guidelines that recommend targeting symptoms, plasma calcium and phosphate values, and urine calcium excretion. Conclusions: The care of patients with chronic hypoparathyroidism involves physicians with very different practices, so guidelines should include and target other specialists as well as endocrinologists. Full adherence to the guidelines is low in France.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Endocr Connect Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: Endocr Connect Año: 2022 Tipo del documento: Article País de afiliación: Francia Pais de publicación: Reino Unido